PANoptosis in cancer: molecular mechanisms and therapeutic potential

Xi Pu1,2, Yuting Wu1, Chen Peng3

  • 1Department of Gastroenterology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China.

Cancer Gene Therapy
|August 21, 2025
PubMed

Insights

PANoptosis, a novel cell death pathway, integrates pyroptosis, apoptosis, and necrotic cell death. Understanding PANoptosis offers new therapeutic strategies for cancer by targeting its role in tumor initiation, progression, and immunity.

Area of Science:

  • Cellular Biology
  • Immunology
  • Oncology

Background:

  • Tumorigenesis is linked to dysregulated cell death.
  • PANoptosis is a newly identified programmed cell death pathway.
  • PANoptosis involves the PANoptosome complex, integrating pyroptosis and apoptosis features.

Purpose of the Study:

  • To review the characteristics and mechanisms of PANoptosis.
  • To discuss the role of PANoptosis in cancer biology and tumor immunity.
  • To explore therapeutic strategies targeting PANoptosis in cancer.

Main Methods:

  • Literature review of programmed cell death pathways.
  • Analysis of PANoptosis assembly and molecular features.
  • Discussion of PANoptosis implications in cancer and immunity.

Main Results:

  • PANoptosis integrates features of pyroptosis, apoptosis, and necrotic cell death.
  • The PANoptosome is a key multiprotein complex in PANoptosis.
  • PANoptosis influences cancer initiation, progression, and the tumor microenvironment.

Conclusions:

  • PANoptosis plays a significant role in cancer biology.
  • Targeting PANoptosis presents a promising therapeutic avenue for cancer treatment.
  • Further research into PANoptosis could revolutionize cancer therapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K